Invesco Ltd. (NYSE:IVZ) saw a downside of -0.37% to close Monday at $18.90 after subtracting -$0.07 on the day. The 5-day average trading volume is 6,489,460 shares of the company’s common stock. It has gained $19.57 in the past week and touched a new high 2 times within the past 5 days. An average of 4,215,070 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,588,284.
IVZ’s 1-month performance is 4.94% or $0.52 on its low of $17.70 reached on 12/30/22. The company’s shares have touched a 52-week low of $13.20 and high of $24.31, with the stock’s rally to the 52-week high happening on 01/12/23. YTD, IVZ has achieved 5.06% or $0.91 and has reached a new high 6 times. However, the current price is down -22.25% from the 52-week high price.
IVZ stock investors last saw insider trading activity on Jun 14.McGreevey Gregory (Senior Managing Director) most recently sold 200,000 shares at $19.60 per share on Mar 08. This transaction cost the insider $3,920,000. President & CEO, FLANAGAN MARTIN L, sold 189,708 shares at a price of $19.51 on Mar 01.
IVZ stock has a beta of 1.37. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.32 while the price-to-book (PB) in the most recent quarter is 0.79.
As well, the company’s long term debt to equity for the quarter ending September 29 was 0.74, while the total debt to equity was 0.74. In terms of profitability, the gross margin trailing 12 months is 68.90%. The firm’s gross profit as reported stood at $1.79 billion against revenue of $6.89 billion.
For the quarterly period ending September 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -86.08% to $177.4 million, while revenue of $121.0 million was 31.79% off the previous quarter. Analysts expected IVZ to announce $0.41 per share in earnings in its latest quarter, but it posted $0.34, representing a -17.10% surprise. EBITDA for the quarter stood at more than $398.1 million. Shareholders hold equity totaling $454.79 million.
Let’s look briefly at Invesco Ltd. (IVZ) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 48.98% to suggest the stock is trending Neutral, with historical volatility in this time period at 21.67%.
The stock’s 5-day moving average is $18.93, reflecting a -2.53% or -$0.49 change from its current price. IVZ is currently trading +1.89% above its 20-day SMA, +11.31% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +14.48% and SMA200 by-16.41%.
Stochastic %K and %D was 46.35% and 49.87% and the average true range (ATR) pointed at 0.55. The RSI (14) points at 51.19%, while the 14-day stochastic is at 45.81% with the period’s ATR at 0.56. The stock’s 9-day MACD Oscillator is pointing at -0.39 and -0.27 on the 14-day charts.
In the most recent analyst report for Invesco Ltd. (NYSE: IVZ), UBS downgraded it to a Neutral rating. They previously had a Buy rating on the stock.